The 2024 MIT Health Science Technology Conference will highlight broad and transformative trends in biology and healthcare, including early-stage discovery, immune cell responses, diagnostics, clinical capabilities, process development, rapid and continuous manufacturing, robotics and automation, and sustainability, all enhanced by artificial intelligence and machine learning technologies. Leading MIT researchers and MIT-connected startups will showcase these advances and discuss their implications for improving human health.
Startup Lightning Talks - 2022 MIT Health Science Technologies Conference The Future of Cell & Gene Therapies
The Blueprint Program supports the journey from scientist to founder, guiding researchers as they transform breakthrough discoveries into real-world solutions. Applications for the fall cohort, sponsored by Mercury, are now open. Over eight weeks, participants gain a comprehensive view of the entrepreneurial path. Expert-led sessions, hands-on workshops, peer learning, and mentorship from investors and seasoned company builders help researchers develop the skills and confidence to launch Tough Tech ventures.
Electronic manufacturer seeking startups in neuromorphic computing.
MIT Startup Exchange will select 4 startups to present and exhibit at the 2025 MIT Health & Science Forum on May 8.
Amgen launches 2023 LabCentral Golden Ticket competition for innovative life science startups, awarding two startups with with lab space, amenities, and services.
Katharine Sepp, Co-founder & CEO, Oxalys Pharmaceuticals
Leading pharmaceutical company in CNS seeks startups to improve performance of clinical trials.
Introduced by Marcus Dahllof, Associate Program Director, MIT Startup Exchange; Cliff Reid, PhD, CEO, Travera; Todd Gierahn, PhD, Cofounder, Honeycomb; Laura Indolfi, PhD, CEO & Cofounder, PanTher Therapeutics; Ulrik Nielsen, PhD, CEO & Cofounder, Torque; Jason Norris, Cofounder, Elektrofi; Patrick Stern, PhD, CEO & Founder, Sextant; Carlos Castro-Gonzalez, PhD, CEO & Cofounder, Leuko Labs; and Alec Nielsen, PhD, Cofounder, Asimov.